Literature DB >> 19744540

Modeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation.

Christa E Flück1, Primus E Mullis, Amit V Pandey.   

Abstract

P450 oxidoreductase (POR) is the obligate electron donor for microsomal cytochrome P450s and mutations in POR cause several metabolic disorders. We have modeled the structure of human P450 oxidoreductase by in silico amino acid replacements in the rat POR crystal structure. The rat POR has 94% homology with human POR and 38 amino acids were replaced to make its sequence identical to human POR. Several rounds of molecular dynamic simulations refined the model and removed structural clashes from side chain alterations of replaced amino acids. This approach has the advantage of keeping the cofactor contacts and structural features of the core enzyme intact which could not be achieved by homology based approaches. The final model from our approach was of high quality and compared well with experimentally determined structures of other PORs. This model will be used for analyzing the structural implications of mutations and polymorphisms in human POR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744540     DOI: 10.1016/j.mce.2009.09.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

Review 1.  The syndrome of 17,20 lyase deficiency.

Authors:  Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

2.  Computational study of missense mutations in phenylalanine hydroxylase.

Authors:  Kamila Réblová; Petr Kulhánek; Lenka Fajkusová
Journal:  J Mol Model       Date:  2015-03-07       Impact factor: 1.810

3.  Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency.

Authors:  Chuanwu Xia; Satya P Panda; Christopher C Marohnic; Pavel Martásek; Bettie Sue Masters; Jung-Ja P Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

4.  Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase.

Authors:  Vishal Agrawal; Ji Ha Choi; Kathleen M Giacomini; Walter L Miller
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

5.  Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.

Authors:  Duanpen Sandee; Kari Morrissey; Vishal Agrawal; Harrison K Tam; Melissa A Kramer; Timothy S Tracy; Kathleen M Giacomini; Walter L Miller
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

6.  Unstable argininosuccinate lyase in variant forms of the urea cycle disorder argininosuccinic aciduria.

Authors:  Liyan Hu; Amit V Pandey; Cécile Balmer; Sandra Eggimann; Véronique Rüfenacht; Jean-Marc Nuoffer; Johannes Häberle
Journal:  J Inherit Metab Dis       Date:  2015-03-17       Impact factor: 4.982

7.  NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology.

Authors:  David S Riddick; Xinxin Ding; C Roland Wolf; Todd D Porter; Amit V Pandey; Qing-Yu Zhang; Jun Gu; Robert D Finn; Sebastien Ronseaux; Lesley A McLaughlin; Colin J Henderson; Ling Zou; Christa E Flück
Journal:  Drug Metab Dispos       Date:  2012-10-19       Impact factor: 3.922

8.  Tobacco Cutworm (Spodoptera Litura) Larvae Silenced in the NADPH-Cytochrome P450 Reductase Gene Show Increased Susceptibility to Phoxim.

Authors:  Hong-Yi Ji; Christian Staehelin; Yan-Ping Jiang; Shi-Wei Liu; Zhi-Hui Ma; Yi-Juan Su; Jia-En Zhang; Rui-Long Wang
Journal:  Int J Mol Sci       Date:  2019-08-06       Impact factor: 5.923

9.  In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.

Authors:  Muhammad Nurhafizuddin; Aziemah Azizi; Long Chiau Ming; Naeem Shafqat
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

10.  Genetic Polymorphisms and In Silico Mutagenesis Analyses of CYP2C9, CYP2D6, and CYPOR Genes in the Pakistani Population.

Authors:  Shabbir Ahmed; Jie Zhou; Zhan Zhou; Shu-Qing Chen
Journal:  Genes (Basel)       Date:  2018-10-22       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.